SUMMARY The ability of a panel of normal human serum samples to inactivate 12 strains of Chiamydia trachomatis, each of a different serovar, was investigated. A wide range of antichlamydial activity was observed, with survival rates of C trachomatis varying from <1% in some experiments to 100% in others. The strain specificity of the anti-chlamydial activity exhibited by individual serum samples was not, however, related to the antigenic cross reactivity between serovars demonstrable by microimmunofluorescence testing, which suggested that type specific antigens were not predominantly involved in the inactivation process.
Introduction
Chlamydia trachomatis is an important human pathogen, which produces disease in the genital tract, eye, and respiratory tract. ' Although chlamydiae are known to infect epithelial cells and often to induce an inflammatory reaction at the site of infection, the pathogenesis of disease produced by such infections is poorly understood. Attempts have been made recently to elucidate the possible role of non-specific host defence mechanisms in the resistance to, and pathogenesis of, chlamydial disease. Yong et al have shown that C-trachomatis organisms are killed by polymorphonuclear leucocytes in vitro,2 a finding which suggests that the development of an acute inflammatory response by the host may help to eliminate chlamydiae from sites of infection.
Work in this laboratory has shown that another potentially important non-specific host defence mechanism is the ability of normal human serum to inactivate C trachomatis.3 Although the serum samples studied had undetectable or low levels of antibody to chlamydiae when tested by microimmunofluorescence, the anti-chlamydial activity required both heat stable and heat labile factors and calcium ions, which suggests the involvement of the classic pathway of complement activation.
In this report we present the results of a study of the specificity of the anti-chlamydial activity of normal human serum samples, which has been investigated by assessing the ability of a panel of serum samples to inactivate different serotypes of C trachomatis.
Materials and methods

CHLAMYDIA TRACHOMA TIS
We used 12 strains of C trachomatis, each belonging to a separate serovar ( 
Discussion
The results presented here confirm our earlier findings that C trachomatis may be susceptible to inactivation by normal human serum and that serum samples from different donors vary in their anti-M F Osborn, A P Johnson, and D Taylor-Robinson 
